Clinical Trial: A Prospective, Two-Arm, Randomized Controlled Study of Lateral Dose Escalation with SBRT Combined with Chemotherapy and Immunotherapy for Local Control in Locally Advanced Rectal Cancer with Lateral Pelvic Lymph Node Metastasis (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Two-Arm, Randomized Controlled Study of Lateral Dose Escalation with SBRT Combined with Chemotherapy and Immunotherapy for Local Control in Locally Advanced Rectal Cancer with Lateral Pelvic Lymph Node Metastasis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130274

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338619

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Prospective, Two-Arm, Randomized Controlled Study of Lateral Dose Escalation with SBRT Combined with Chemotherapy and Immunotherapy for Local Control in Locally Advanced Rectal Cancer with Lateral Pelvic Lymph Node Metastasis (China)